Please login to the form below

Not currently logged in
Email:
Password:

SITC 2019

This page shows the latest SITC 2019 news and features for those working in and with pharma, biotech and healthcare.

Trial backs Inovio/Sanofi combo in hard-to-treat brain cancer

Trial backs Inovio/Sanofi combo in hard-to-treat brain cancer

The results will be presented this week at the Society for Immunotherapy of Cancer (SITC) annual congress in National Harbor, Maryland. ... 6th November 2019.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...